tDCS in Patients With Disorders of Consciousness

Sponsor
First Affiliated Hospital of Zhejiang University (Other)
Overall Status
Withdrawn
CT.gov ID
NCT03475537
Collaborator
(none)
0
1
1
21
0

Study Details

Study Description

Brief Summary

test

Condition or Disease Intervention/Treatment Phase
  • Device: transcranial direct current stimulation
N/A

Detailed Description

Neurostimulation techniques such as deep brain stimulation (DBS) and spinal cord stimulation (SCS) have been used to treat DOC. Although these techniques have been shown to increase patient response, there are still some limitations. For example, DBS requires craniotomy and may increase the risk of intracranial hemorrhage and infection. In addition, the complexity and cost of these technologies also limit their potential applications.

Study Design

Study Type:
Interventional
Actual Enrollment :
0 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
The Usage of tDCS in Patients With Disorders of Consciousness
Anticipated Study Start Date :
Apr 15, 2018
Anticipated Primary Completion Date :
Jul 15, 2019
Anticipated Study Completion Date :
Jan 15, 2020

Arms and Interventions

Arm Intervention/Treatment
Experimental: the treatment of transcranial direct current stimulation

Direct current was applied by a battery-driven constant current stimulator using saline-soaked surface sponge electrodes (7×5 cm) with the anode positioned over the left dorsolateral prefrontal cortex (F3 according to the 10-20 international system for EEG placement) and the cathode placed over the right supraorbital region. During real tDCS, the current was increased to 2 mA from the onset of stimulation and applied for 20 minutes.

Device: transcranial direct current stimulation
the treatment of transcranial direct current stimulation

Outcome Measures

Primary Outcome Measures

  1. improvement of CRS-R [7 days]

    test

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
No
Inclusion Criteria:

Patients with DOC: VS and MCS (the cause of unification is: traumatic brain injury, the course of more than 1 month, not more than 1 year ; age 18-65; Past history without a mental disorder; No previous alcohol or substance abuse; No epilepsy or frequent spontaneous movement; No benzodiazepines; No moderate or severe hydrocephalus, All patients were right handed.

Exclusion Criteria:

Exclusion of organic heart disease, such as sinus bradycardia, arrhythmia; exclusion of patients with intracranial metal devices, pacemakers or any other device.

Contacts and Locations

Locations

Site City State Country Postal Code
1 The First Affiliated Hospital, Zhejiang University Hangzhou Zhejiang China

Sponsors and Collaborators

  • First Affiliated Hospital of Zhejiang University

Investigators

  • Principal Investigator: Benyan Luo, Department of Neurology and Brain Medical Centre The First Affiliated Hospital, School of Medicine, Zhejiang University 79 Qingchun Road, Hangzhou

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
First Affiliated Hospital of Zhejiang University
ClinicalTrials.gov Identifier:
NCT03475537
Other Study ID Numbers:
  • test
First Posted:
Mar 23, 2018
Last Update Posted:
Oct 23, 2019
Last Verified:
Mar 1, 2018
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 23, 2019